FDA Approved: TYMLOS — Supplemental Application (Radius Health, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TYMLOS (abaloparatide) from Radius Health, Inc., resulting in labeling updates via a supplemental approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Tymlos (abaloparatide)

Snippet

SUPPL AP for TYMLOS (ABALOPARATIDE)